Administration, Inhalation

"Administration, Inhalation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.

Descriptor ID	D000280
MeSH Number(s)	E02.319.267.050
Concept/Terms	Administration, Inhalation Administration, Inhalation Drug Administration, Respiratory Administration, Respiratory Drug Respiratory Drug Administration Inhalation Drug Administration Drug Administration, Inhalation Administration, Inhalation Drug Inhalation Administration Drug Aerosol Therapy Drug Aerosol Therapy Aerosol Therapy, Drug Therapy, Drug Aerosol Drug Therapy, Aerosol Aerosol Drug Therapy Therapy, Aerosol Drug Inhalation of Drugs Inhalation of Drugs

Below are MeSH descriptors whose meaning is more general than "Administration, Inhalation".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Administration, Inhalation [E02.319.267.050]

Below are MeSH descriptors whose meaning is related to "Administration, Inhalation".

Below are MeSH descriptors whose meaning is more specific than "Administration, Inhalation".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Administration, Inhalation" by people in this website by year, and whether "Administration, Inhalation" was a major or minor topic of these publications.

Bar chart showing 156 publications over 29 distinct years, with a maximum of 13 publications in 2006

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
1996	3	3
1997	4	4
1998	5	5
1999	9	9
2000	3	3
2001	3	3
2002	2	2
2003	6	6
2004	8	8
2005	5	5
2006	13	13
2007	6	6
2008	4	4
2009	5	5
2010	5	5
2011	10	10
2012	6	6
2013	3	3
2014	5	5
2015	5	5
2016	4	4
2017	6	6
2018	8	8
2019	8	8
2020	4	4
2021	2	2
2022	4	4
2023	5	5
2024	5	5

Below are the most recent publications written about "Administration, Inhalation" by people in Profiles.

Skolnik N, Yawn BP, Correia de Sousa J, V?zquez MMM, Barnard A, Wright WL, Ulrich A, Winders T, Brunton S. Best practice advice for asthma exacerbation prevention and management in primary care: an international expert consensus. NPJ Prim Care Respir Med. 2024 Nov 17; 34(1):39.

View in: PubMed
G?mez LF, Kinnee E, Kaufman JD, Young MT, Fitzpatrick AM, Phipatanakul W, Mauger DT, McClure LA, Bilal U, Holguin F, Clougherty JE. Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial. Respir Med. 2024 Nov-Dec; 234:107853.

View in: PubMed
Levy ML, Kocks JWH, Bosnic-Anticevich S, Safioti G, Reich M, Depietro M, Castro M, Farooqui N, Lugogo NL, Brown R, Hill T, Li T, Chrystyn H. Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler. NPJ Prim Care Respir Med. 2024 08 20; 34(1):23.

View in: PubMed
Ruskin JN, Camm AJ, Dufton C, Woite-Silva AC, Tuininga Y, Badings E, De Jong JSSG, Oosterhof T, Aksoy I, Kuijper AFM, Van Gelder IC, van Dijk V, Nuyens D, Schellings D, Lee MY, Kowey PR, Crijns HJGM, Maupas J, Belardinelli L. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial. JACC Clin Electrophysiol. 2024 Jun; 10(6):1021-1033.

View in: PubMed
Panettieri RA, Chipps BE, Skolnik N, George M, Murphy K, Lugogo N. The Use of Albuterol/Budesonide as Reliever Therapy to Reduce Asthma Exacerbations. J Allergy Clin Immunol Pract. 2024 04; 12(4):882-888.

View in: PubMed
Mosnaim GS, Hoyte FCL, Safioti G, Brown R, Hill TD, Li T, Sagalovich K, DePietro M, Wechsler ME. Effectiveness of a Maintenance and Reliever Digihaler System in Asthma: 24-Week Randomized Study (CONNECT2). J Allergy Clin Immunol Pract. 2024 02; 12(2):385-395.e4.

View in: PubMed
Fraga MV, Dysart KC, Stoller JZ, Huber M, Fedec A, Mercer-Rosa L, Kirpalani H. Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia. Neonatology. 2023; 120(5):633-641.

View in: PubMed
Kolewe EL, Padhye S, Woodward IR, Feng Y, Briddell JW, Fromen CA. A Pediatric Upper Airway Library to Evaluate Interpatient Variability of In Silico Aerosol Deposition. AAPS PharmSciTech. 2023 Jul 31; 24(6):162.

View in: PubMed
Skolnik N, Norden M, Lugogo N, Wright W. Use of ICS and Fast-Acting Bronchodilators in Asthma: Past, Present, and Future. J Fam Pract. 2023 07; 72(6 Suppl):S61-S70.

View in: PubMed
Mintz M, Barjaktarevic I, Mahler DA, Make B, Skolnik N, Yawn B, Zeyzus-Johns B, Hanania NA. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review. Mayo Clin Proc. 2023 02; 98(2):301-315.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement